| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 763921 | BE001215IP | FORTASEC 2 MG CAPSULAS DURAS | FORTASEC 2 MG CAPSULAS DURAS, 20 cápsulas | 2 mg | 5 | 20 | 43 | 20 cápsulas | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/BE001215IP/BE001215IP_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 44580 | ELAM PHARMA LABS S.L. | 2023-12-18 | 1 | 1 | 1 | 2023-12-19 | 2023-12-18 | 1 | 2024-04-26 | View Edit Delete | ||||||||||||
| 764026 | 3126703CIP | EZETROL 10 MG COMPRIMIDOS | EZETROL 10 MG COMPRIMIDOS, 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/3126703CIP/3126703CIP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48716 | ELAM PHARMA LABS S.L. | 2024-01-15 | 1 | 1 | 1 | 2024-01-16 | 2024-01-15 | 1 | 2024-04-02 | View Edit Delete | ||||||||||||
| 764088 | 07383014IP2 | JANUVIA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | JANUVIA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 100 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07383014IP2/07383014IP2_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07383014IP2/07383014IP2_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34945 | ELAM PHARMA LABS S.L. | 2024-01-22 | 1 | 1 | 1 | 2024-01-23 | 2024-01-22 | 1 | 2024-04-26 | View Edit Delete | ||||||||||||
| 764130 | 819420150119 | CARDYL 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | CARDYL 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/819420150119/819420150119_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33758 | ELAM PHARMA LABS S.L. | 2024-01-30 | 1 | 1 | 1 | 2024-01-31 | 2024-01-30 | 1 | 2024-05-22 | View Edit Delete | ||||||||||||
| 764131 | 819520150119 | CARDYL 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | CARDYL 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 80 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/819520150119/819520150119_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33758 | ELAM PHARMA LABS S.L. | 2024-02-01 | 1 | 1 | 1 | 2024-02-02 | 2024-02-01 | 1 | 2024-05-22 | View Edit Delete | ||||||||||||
| 764298 | 97046027IP1 | APROVEL 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | APROVEL 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 300 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/97046027IP1/97046027IP1_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/97046027IP1/97046027IP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41749 | ELAM PHARMA LABS S.L. | 2024-02-13 | 1 | 1 | 1 | 2024-02-14 | 2024-02-13 | 1 | 2024-04-26 | View Edit Delete | ||||||||||||
| 764309 | 07383015IP2 | JANUVIA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | JANUVIA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 56 comprimidos | 100 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07383015IP2/07383015IP2_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07383015IP2/07383015IP2_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34945 | ELAM PHARMA LABS S.L. | 2024-02-13 | 1 | 1 | 1 | 2024-02-14 | 2024-02-13 | 1 | 2024-04-26 | View Edit Delete | ||||||||||||
| 764328 | 038983161IP2 | CAPENON 40 MG/5 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA | CAPENON 40 MG/5 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA, 28 comprimidos | 40 mg/5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/038983161IP2/038983161IP2_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28226 | ELAM PHARMA LABS S.L. | 2024-02-15 | 1 | 1 | 1 | 2024-02-16 | 2024-02-15 | 1 | 2024-10-02 | View Edit Delete | ||||||||||||
| 763724 | 12076 | COMBIGAN 2 MG/ML + 5 MG/ML COLIRIO EN SOLUCION | COMBIGAN 2 MG/ML + 5 MG/ML COLIRIO EN SOLUCION, 1 frasco de 5 ml | 2 mg/ml + 5 mg/ml | 6 | 5 | 26 | 1 frasco de 5 ml | 0 | 0 | 1 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/12076/12076_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41671 | ELAM PHARMA LABS S.L. | 2023-11-08 | 1 | 1 | 1 | 2023-11-09 | 2023-11-08 | 1 | 2024-03-05 | View Edit Delete | ||||||||||||
| 763900 | 13380-2020-01-24IP | VOLTADOL FORTE 23,2 MG/G GEL | VOLTADOL FORTE 23,2 MG/G GEL, 1 tubo de 100 g | 20 mg/g | 44 | 100 | 21 | 1 tubo de 100 g | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/13380-2020-01-24IP/13380-2020-01-24IP_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29104 | ELAM PHARMA LABS S.L. | 2023-12-14 | 1 | 1 | 1 | 2023-12-15 | 2023-12-14 | 1 | 2025-07-11 | View Edit Delete | ||||||||||||
| 763460 | 113882002IP | ABILIFY MAINTENA 400 MG POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA | ABILIFY MAINTENA 400 MG POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA, 1 vial + 1 vial de disolvente | 400 mg | 45 | 1 | 34 | 1 vial + 1 vial de disolvente | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/113882002IP/113882002IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/113882002IP/113882002IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29813 | ELAM PHARMA LABS S.L. | 2023-09-29 | 1 | 1 | 1 | 2023-09-30 | 2023-09-29 | 1 | 2026-04-13 | View Edit Delete | ||||||||||||
| 764491 | 08470005IP | VIMPAT 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | VIMPAT 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 56 comprimidos | 100 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08470005IP/08470005IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08470005IP/08470005IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8910 | ELAM PHARMA LABS S.L. | 2024-03-08 | 1 | 1 | 1 | 2024-03-09 | 2024-03-08 | 0 | 2024-05-22 | View Edit Delete | ||||||||||||
| 764492 | 08470011IP | VIMPAT 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | VIMPAT 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 56 comprimidos | 200 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08470011IP/08470011IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08470011IP/08470011IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8910 | ELAM PHARMA LABS S.L. | 2024-03-08 | 1 | 1 | 1 | 2024-03-09 | 2024-03-08 | 0 | 2024-05-22 | View Edit Delete | ||||||||||||
| 764526 | 05310002IP1 | FOSAVANCE 70 MG/2.800 UI COMPRIMIDOS | FOSAVANCE 70 MG/2.800 UI COMPRIMIDOS, 4 comprimidos | 70 mg/2.800 UI | 5 | 4 | 10 | 4 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/05310002IP1/05310002IP1_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/05310002IP1/05310002IP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48716 | ELAM PHARMA LABS S.L. | 2024-03-12 | 1 | 1 | 1 | 2024-03-13 | 2024-03-12 | 1 | 2024-05-22 | View Edit Delete | ||||||||||||
| 764527 | 05310007IP2 | FOSAVANCE 70 MG/5.600 UI COMPRIMIDOS | FOSAVANCE 70 MG/5.600 UI COMPRIMIDOS, 4 comprimidos | 70 mg/5.600 UI | 5 | 4 | 10 | 4 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/05310007IP2/05310007IP2_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/05310007IP2/05310007IP2_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48716 | ELAM PHARMA LABS S.L. | 2024-03-12 | 1 | 1 | 1 | 2024-03-13 | 2024-03-12 | 1 | 2024-05-22 | View Edit Delete | ||||||||||||
| 764630 | 0612198C | ARICEPT 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ARICEPT 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/0612198C/0612198C_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 7473 | ELAM PHARMA LABS S.L. | 2024-03-27 | 1 | 1 | 1 | 2024-03-28 | 2024-03-27 | 1 | 2024-05-22 | View Edit Delete | ||||||||||||
| 764651 | 8194201508 | ZARATOR 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | ZARATOR 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/8194201508/8194201508_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33758 | ELAM PHARMA LABS S.L. | 2024-04-02 | 1 | 1 | 1 | 2024-04-03 | 2024-04-02 | 1 | 2024-06-19 | View Edit Delete | ||||||||||||
| 764652 | 8195201508 | ZARATOR 80 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | ZARATOR 80 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 80 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/8195201508/8195201508_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33758 | ELAM PHARMA LABS S.L. | 2024-04-02 | 1 | 1 | 1 | 2024-04-03 | 2024-04-02 | 1 | 2024-06-19 | View Edit Delete | ||||||||||||
| 764659 | PA2242006001IP | PAZITAL 37,5 mg/325 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | PAZITAL 37,5 mg/325 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 60 comprimidos | 37,5 mg/325 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/PA2242006001IP/PA2242006001IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29459 | ELAM PHARMA LABS S.L. | 2024-04-04 | 1 | 1 | 1 | 2024-04-05 | 2024-04-04 | 0 | 2025-06-19 | View Edit Delete | ||||||||||||
| 764764 | OGYI-T-20519-22IP | ZARELIS RETARD 150 MG COMPRIMIDOS DE LIBERACION PROLONGADA | ZARELIS RETARD 150 MG COMPRIMIDOS DE LIBERACION PROLONGADA, 30 comprimidos | 150 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/OGYI-T-20519-22IP/OGYI-T-20519-22IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 67967 | ELAM PHARMA LABS S.L. | 2024-04-18 | 1 | 1 | 1 | 2024-04-19 | 2024-04-18 | 1 | 2025-08-27 | View Edit Delete |
Page 252 of 1035, showing 20 records out of 20697 total, starting on record 5021, ending on 5040